Featured News

Consider joining the CeDar Rose Study, a remote celiac disease study that will monitor individual gluten tolerance.

We are pleased to announce that CDF Board Member, Kristin Yarema, PhD, was honored as a 2022 Medical Marketing & Media Woman of Distinction.

The Celiac Disease Foundation is in discussion with a team at the University of Colorado, Denver to develop the first-ever, FDA-approved pediatric PRO (patient-reported outcome tool).

On April 8 and April 9, the Celiac Disease Foundation is sponsoring the Columbia University Celiac Disease Center International Symposium on Celiac Disease.

The Celiac Disease Foundation is matching donations, dollar for dollar, up to $25,000. Together we can protect those with celiac disease in crisis. 

To share with you some insight into our advocacy work, I recently interviewed Mark Van de Water, Senior Advisor at Baker Donelson.

Researchers found that children initially diagnosed with potential celiac disease had a high risk of developing celiac disease.

I am pleased to share a research grant awarded to the Dubcovsky Lab at UC Davis for Development of a Novel Dietary Treatment for Celiac Disease that may significantly reduce the suffering experienced by our patient community.

We are pleased to share the video recording of Dr. Jocelyn Silvester discussing what you need to know about pediatric celiac disease now and in the future.

At UEGW, researchers from Takeda, the University of Sheffield, Columbia University, Coeliac UK, and CDF virtually presented a study entitled, Experiences of a gluten-free diet in patients with celiac disease: a multi-national survey.